Feb 28
|
1 Biotech Stock to Buy in 2025, and 1 to Avoid
|
Feb 28
|
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
|
Feb 26
|
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory
|
Feb 26
|
Is Viking Therapeutics a Buy Right Now?
|
Feb 25
|
Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect
|
Feb 24
|
Viking Therapeutics (VKTX): Among the Oversold Biotech Stocks to Buy Now
|
Feb 24
|
Should You Buy VKTX Stock Amid Renewed M&A Speculations?
|
Feb 24
|
Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
|
Feb 22
|
Why Viking Therapeutics Inc. (VKTX) Surged On Friday?
|
Feb 20
|
Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday?
|
Feb 5
|
Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers
|
Feb 5
|
Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
|
Feb 5
|
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
|
Feb 4
|
Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics?
|
Feb 2
|
Jim Cramer’s Take on Viking Therapeutics (VKTX): “Sell Viking Therapeutics and Roll it into Viking Holdings”
|
Feb 2
|
This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?
|
Jan 31
|
Jim Cramer Says ‘I Want You To Sell Viking Therapeutics, Inc. (VKTX) And Roll It Into Viking Holdings’
|
Jan 30
|
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
|
Jan 30
|
Viking Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?
|
Jan 4
|
Why Viking Therapeutics Stock Plummeted by 24% in December
|